Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome

scientific article published on 12 March 2007

Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.LEUKRES.2007.01.018
P698PubMed publication ID17350683

P2093author name stringTakeshi Sugawara
Kazunori Murai
Shigeki Ito
Yoji Ishida
Keijiro Suzuki
Tatsuo Oyake
Toshiyuki Uchiyama
Shima Onodera
Yasuhiko Tsukushi
Yusei Aoki
P433issue10
P921main subjectmyelodysplastic syndromeQ954625
P304page(s)1343-1349
P577publication date2007-03-12
P1433published inLeukemia ResearchQ15716445
P1476titleClinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome
P478volume31

Reverse relations

cites work (P2860)
Q38110693Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.
Q35587260Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf.
Q35265653Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.
Q92661860MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer
Q37871662MOB control: reviewing a conserved family of kinase regulators
Q28478308Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues
Q86478970[NT5C2 expression in children with acute leukemia and its clinical significance]

Search more.